Protective role of OPN-High macrophages in NASH
OPN-High 巨噬细胞在 NASH 中的保护作用
基本信息
- 批准号:10752928
- 负责人:
- 金额:$ 53.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-05 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:ARG2 geneAdipose tissueAdultBioenergeticsBody FluidsCell physiologyCellsChildCholesterolClinicalCollagenDataDepositionDevelopmentDietEmbryoEquilibriumEventExtracellular MatrixFatty LiverFatty acid glycerol estersFibrosisFructoseGene Expression ProfileHepaticHepatic Stellate CellHepatocyteHeterogeneityHumanHuman MilkImmune systemInfantInfiltrationInflammatoryInterventionKnock-inKnockout MiceKnowledgeKupffer CellsLaboratoriesLinkLipidsLiverLiver FibrosisLiver diseasesLocationMacrophageMessenger RNAMitochondriaModelingMonounsaturated Fatty AcidsMusMyeloid CellsNitric OxideObesityPathogenesisPathologicPathway interactionsPatientsPhenotypePhysiological ProcessesPlasmaPreventiveProductionProteinsRegimenRegulator GenesRoleSaturated Fatty AcidsSignal TransductionSignaling ProteinTestingTherapeuticTissuesTriglyceridesUmbilical cord structureUp-Regulationcell behaviorfatty acid oxidationfeedingintercellular communicationlipid metabolismlipidomicsliver transplantationmRNA Expressionmonocytenitrosative stressnonalcoholic steatohepatitisnovel therapeuticsosteopontinoverexpressionpreventpromoterrecruitsingle-cell RNA sequencingtherapeutic evaluationtranscriptometranscriptomicsurea cycle
项目摘要
Non-alcoholic steatohepatitis (NASH) is emerging as a major worldwide cause of liver disease in children and adults. Recent studies demonstrate substantial heterogeneity in the phenotype of macrophages (MFs) infiltrating the liver during NASH. Recruited MFs exist as two subsets, with distinct activation states: (1) those closely resembling homeostatic Kupffer cells (KCs), or (2) lipid-associated MFs (LAMs). In 2020, a cluster of LAMs with high expression of osteopontin (OPN) was identified in livers with NASH. Notably, LAMs are differentially activated, compared to resident- and monocyte-derived KCs, and with a distinct ability to metabolize lipids. However, whether they also crosstalk with neighboring cells, to prevent steatosis and fibrosis in NASH, remains unknown. While recruitment of MFs into the liver, and subsequent activation, are considered proinflammatory and profibrotic events, currently a significant knowledge gap is a lack of understanding of whether OPNHigh MFs, are detrimental or protective in NASH. Preliminary data demonstrates that Spp1KI Mye are protected, whereas Spp1ΔMye have worse NASH activity scores than WT mice. Thus, our results suggest a paradigm shift, in that OPNHigh MFs may protect from NASH. Yet, the intercellular communication, and preventive and therapeutic potential of OPNHigh MFs, remain to be determined. Our overarching hypothesis is that OPNHigh MFs, by signaling to hepatocytes (HEPs) and hepatic stellate cells (HSCs), reduce liver steatosis and fibrosis, and protect from NASH. Aim 1 is to identify how OPNHigh MFs protect from steatosis. We hypothesize that OPNHigh MFs signal HEPs to upregulate arginase-2 (ARG2), which increases mitochondrial bioenergetics and fatty acid oxidation (FAO), reduces nitrosative stress, and protects from steatosis. To test this, first, we will identify the OPNHigh MF ‘secretome’ proteins that signal HEPs to upregulate ARG2; second, we will determine how the identified OPNHigh MF secretome proteins transactivate the ARG2 promoter, in HEPs; and third, we will elucidate how ARG2 increases mitochondrial bioenergetics and FAO, and reduces nitrosative stress, in HEPs. Aim 2 is to dissect how OPNHigh MFs protect from fibrosis. We hypothesize that OPNHigh MFs signal through secretome proteins to lower collagen-I, and/or modify the ‘matrisome’ landscape, to prevent fibrosis, and regulate cell behavior, in NASH. To prove this, first, we will identify the OPNHigh MF secretome proteins that signal HSCs to lower collagen-I deposition and/or increase its degradation; second, we will analyze whether OPNHigh MFs modify the matrisome landscape, and establish the OPNHigh MF-ECM correlation network; and third, we will perform liver scRNA-seq, and computationally identify how the OPNHigh MF-ECM network regulates cell behavior in NASH.
非酒精性脂肪性肝炎(NASH)正在成为儿童和成人肝脏疾病的主要全球原因。最近的研究表明,在NASH期间浸润肝脏的巨噬细胞(MFs)的表型存在实质性异质性。募集的MFs以两个亚群存在,具有不同的激活状态:(1)与稳态库普弗细胞(KC)非常相似的那些,或(2)脂质相关的MFs(LAM)。2020年,在NASH肝脏中发现了一组骨桥蛋白(OPN)高表达的LAM。值得注意的是,与居民和单核细胞来源的KC相比,LAM被差异活化,并且具有独特的代谢脂质的能力。然而,它们是否也与邻近细胞相互作用,以防止NASH中的脂肪变性和纤维化,仍然是未知的。虽然将MF募集到肝脏中以及随后的活化被认为是促炎性和促纤维化事件,但目前的重大知识缺口是缺乏对OPNHigh MF在NASH中是有害的还是保护性的理解。初步数据表明,Spp 1 KI Mye受到保护,而Spp 1 ΔMye的NASH活性评分比WT小鼠更差。因此,我们的研究结果表明了一种范式转变,即OPN高MFs可以保护NASH。然而,OPNHigh MFs的细胞间通讯以及预防和治疗潜力仍有待确定。我们的总体假设是,OPN高MFs通过向肝细胞(HEP)和肝星状细胞(HSC)发出信号,减少肝脏脂肪变性和纤维化,并防止NASH。目的1是确定OPN高MFs如何防止脂肪变性。我们假设,OPN高MFs信号HEP上调脂肪酶-2(ARG 2),增加线粒体生物能量学和脂肪酸氧化(FAO),减少亚硝化应激,并防止脂肪变性。为了测试这一点,首先,我们将确定信号HEP上调ARG 2的OPNHigh MF“分泌组”蛋白;其次,我们将确定所确定的OPNHigh MF分泌组蛋白如何在HEP中反式激活ARG 2启动子;第三,我们将阐明ARG 2如何在HEP中增加线粒体生物能学和FAO,并减少亚硝化应激。目的2是剖析OPN高MFs如何保护纤维化。我们假设,在NASH中,OPN高MFs通过分泌组蛋白发出信号以降低胶原-I和/或修改“基质体”景观,从而防止纤维化并调节细胞行为。为了证明这一点,首先,我们将鉴定向HSC发出信号以降低胶原-I沉积和/或增加其降解的OPNHigh MF分泌组蛋白;其次,我们将分析OPNHigh MF是否改变基质体景观,并建立OPNHigh MF-ECM相关网络;第三,我们将进行肝脏scRNA-seq,并通过计算确定OPNHigh MF-ECM网络如何调节NASH中的细胞行为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Natalia Nieto其他文献
Natalia Nieto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Natalia Nieto', 18)}}的其他基金
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease
肝脏来源的蛋白质复合物作为促炎程序的调节剂的致病作用,该程序驱动酒精性肝病中的肝脏和肠道损伤
- 批准号:
10663785 - 财政年份:2021
- 资助金额:
$ 53.38万 - 项目类别:
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease
肝脏来源的蛋白质复合物作为促炎程序的调节剂的致病作用,该程序驱动酒精性肝病中的肝脏和肠道损伤
- 批准号:
10358521 - 财政年份:2021
- 资助金额:
$ 53.38万 - 项目类别:
High-mobility group box-1 and alcoholic liver disease
高迁移率族box-1与酒精性肝病
- 批准号:
10197739 - 财政年份:2018
- 资助金额:
$ 53.38万 - 项目类别:
High-mobility group box-1 and alcoholic liver disease
高迁移率族box-1与酒精性肝病
- 批准号:
10451824 - 财政年份:2018
- 资助金额:
$ 53.38万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
9088188 - 财政年份:2015
- 资助金额:
$ 53.38万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
9025179 - 财政年份:2015
- 资助金额:
$ 53.38万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
8428356 - 财政年份:2012
- 资助金额:
$ 53.38万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
8549929 - 财政年份:2012
- 资助金额:
$ 53.38万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
8693890 - 财政年份:2012
- 资助金额:
$ 53.38万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 53.38万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 53.38万 - 项目类别:
Research Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别:
Operating Grants
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
- 批准号:
10605981 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 53.38万 - 项目类别: